| Thuy-tien Diep, | |
|
4348 Bonita Rd, Bonita, CA 91902-1421 | |
| (619) 267-1617 | |
| Not Available |
| Full Name | Thuy-tien Diep |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 4348 Bonita Rd, Bonita, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306355094 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 77026 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Thuy-tien Diep, Po Box 710331, San Diego, CA 92171-0331 Ph: () - | Thuy-tien Diep, 4348 Bonita Rd, Bonita, CA 91902-1421 Ph: (619) 267-1617 |
News Archive
The Board of Directors of Ipsen, chaired by Marc de Garidel, met on 28 February 2012 to review the Group's results for 2011, published today.
More than 1.7 billion people worldwide may be classified as overweight and need appropriate medical or surgical treatment with the goal of sustainable weight loss. But for weight management programs to be effective, patients must complete them, states a study published in the Canadian Journal of Surgery (CJS) that analyzed drop-out rates and predictors of attrition within a publicly-funded adult weight management program.
Kennedy Krieger Institute announced today the opening of the new Center for Genetic Muscle Disorders that will improve and expand services to individuals with muscle disorders such as muscular dystrophy and congenital myopathy in the Baltimore/Washington region and across the nation. The Center provides expert clinical care to children and adults with these disorders, and offers leading research programs both in the clinical and laboratory setting.
Celgene International Sàrl, a subsidiary of Celgene Corporation, today reported final results from the phase II portion of a multi-center phase I/II study evaluating combination therapy with REVLIMID (lenalidomide) and VIDAZA (azacitidine) in patients with higher-risk myelodysplastic syndromes (MDS) not previously treated with either drug.
› Verified 1 days ago
Mr. Wai-chuen Mark Siu, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3955 Bonita Rd, Bonita, CA 91902 Phone: 619-409-6404 | |
Kristi Lee, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4348 Bonita Road, Bonita, CA 91902 Phone: 619-267-1729 | |
Michele Alaine Dumstorff, PHARM. D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3955 Bonita Rd, Bonita, CA 91902 Phone: 619-409-6404 Fax: 619-409-6410 | |
Christina Mancilla Jenkins, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3955 Bonita Rd, Bonita, CA 91902 Phone: 619-409-6408 Fax: 619-409-6410 | |
Wonja Paik Kang, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3955 Bonita Rd, Bonita, CA 91902 Phone: 619-409-6404 | |
Mr. Duncan Jay Woo, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3955 Bonita Rd, Bonita, CA 91902 Phone: 619-409-6404 Fax: 619-406-6410 |